January 26, 2018
Takeda Pharmaceutical and its US partner Zinfandel Pharmaceuticals said on January 25 that they have called off a large-scale study evaluating the potential of the Japanese giant’s major diabetes drug Actos (pioglitazone) as an Alzheimer’s therapy after it showed an...read more